IBDEI043 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4892,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,4892,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,4893,0)
 ;;=B36.0^^22^301^19
 ;;^UTILITY(U,$J,358.3,4893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4893,1,3,0)
 ;;=3^Pityriasis Versicolor
 ;;^UTILITY(U,$J,358.3,4893,1,4,0)
 ;;=4^B36.0
 ;;^UTILITY(U,$J,358.3,4893,2)
 ;;=^5000608
 ;;^UTILITY(U,$J,358.3,4894,0)
 ;;=Z92.3^^22^301^8
 ;;^UTILITY(U,$J,358.3,4894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4894,1,3,0)
 ;;=3^Personal Hx of Irradiation (Therapeutic)
 ;;^UTILITY(U,$J,358.3,4894,1,4,0)
 ;;=4^Z92.3
 ;;^UTILITY(U,$J,358.3,4894,2)
 ;;=^5063637
 ;;^UTILITY(U,$J,358.3,4895,0)
 ;;=Z91.82^^22^301^11
 ;;^UTILITY(U,$J,358.3,4895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4895,1,3,0)
 ;;=3^Personal Hx of Military Deployment
 ;;^UTILITY(U,$J,358.3,4895,1,4,0)
 ;;=4^Z91.82
 ;;^UTILITY(U,$J,358.3,4895,2)
 ;;=^5063626
 ;;^UTILITY(U,$J,358.3,4896,0)
 ;;=L66.0^^22^301^39
 ;;^UTILITY(U,$J,358.3,4896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4896,1,3,0)
 ;;=3^Pseudopelade
 ;;^UTILITY(U,$J,358.3,4896,1,4,0)
 ;;=4^L66.0
 ;;^UTILITY(U,$J,358.3,4896,2)
 ;;=^191705
 ;;^UTILITY(U,$J,358.3,4897,0)
 ;;=Z85.820^^22^301^9
 ;;^UTILITY(U,$J,358.3,4897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4897,1,3,0)
 ;;=3^Personal Hx of Malig Melanoma of Skin
 ;;^UTILITY(U,$J,358.3,4897,1,4,0)
 ;;=4^Z85.820
 ;;^UTILITY(U,$J,358.3,4897,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,4898,0)
 ;;=Z87.2^^22^301^12
 ;;^UTILITY(U,$J,358.3,4898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4898,1,3,0)
 ;;=3^Personal Hx of Skin Diseases
 ;;^UTILITY(U,$J,358.3,4898,1,4,0)
 ;;=4^Z87.2
 ;;^UTILITY(U,$J,358.3,4898,2)
 ;;=^5063484
 ;;^UTILITY(U,$J,358.3,4899,0)
 ;;=L08.0^^22^301^46
 ;;^UTILITY(U,$J,358.3,4899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4899,1,3,0)
 ;;=3^Pyoderma
 ;;^UTILITY(U,$J,358.3,4899,1,4,0)
 ;;=4^L08.0
 ;;^UTILITY(U,$J,358.3,4899,2)
 ;;=^5009078
 ;;^UTILITY(U,$J,358.3,4900,0)
 ;;=L73.1^^22^301^38
 ;;^UTILITY(U,$J,358.3,4900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4900,1,3,0)
 ;;=3^Pseudofolliculitis Barbae
 ;;^UTILITY(U,$J,358.3,4900,1,4,0)
 ;;=4^L73.1
 ;;^UTILITY(U,$J,358.3,4900,2)
 ;;=^5009284
 ;;^UTILITY(U,$J,358.3,4901,0)
 ;;=L42.^^22^301^17
 ;;^UTILITY(U,$J,358.3,4901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4901,1,3,0)
 ;;=3^Pityriasis Rosea
 ;;^UTILITY(U,$J,358.3,4901,1,4,0)
 ;;=4^L42.
 ;;^UTILITY(U,$J,358.3,4901,2)
 ;;=^94726
 ;;^UTILITY(U,$J,358.3,4902,0)
 ;;=L44.0^^22^301^18
 ;;^UTILITY(U,$J,358.3,4902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4902,1,3,0)
 ;;=3^Pityriasis Rubra Pilaris
 ;;^UTILITY(U,$J,358.3,4902,1,4,0)
 ;;=4^L44.0
 ;;^UTILITY(U,$J,358.3,4902,2)
 ;;=^94729
 ;;^UTILITY(U,$J,358.3,4903,0)
 ;;=L29.0^^22^301^32
 ;;^UTILITY(U,$J,358.3,4903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4903,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,4903,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,4903,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,4904,0)
 ;;=L29.1^^22^301^34
 ;;^UTILITY(U,$J,358.3,4904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4904,1,3,0)
 ;;=3^Pruritus Scroti
 ;;^UTILITY(U,$J,358.3,4904,1,4,0)
 ;;=4^L29.1
 ;;^UTILITY(U,$J,358.3,4904,2)
 ;;=^5009150
 ;;^UTILITY(U,$J,358.3,4905,0)
 ;;=L29.2^^22^301^35
 ;;^UTILITY(U,$J,358.3,4905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4905,1,3,0)
 ;;=3^Pruritus Vulvae
 ;;^UTILITY(U,$J,358.3,4905,1,4,0)
 ;;=4^L29.2
 ;;^UTILITY(U,$J,358.3,4905,2)
 ;;=^100075
 ;;^UTILITY(U,$J,358.3,4906,0)
 ;;=L29.3^^22^301^36
 ;;^UTILITY(U,$J,358.3,4906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4906,1,3,0)
 ;;=3^Pruritus,Anogenital,Unspec
 ;;^UTILITY(U,$J,358.3,4906,1,4,0)
 ;;=4^L29.3
 ;;^UTILITY(U,$J,358.3,4906,2)
 ;;=^5009151
 ;;^UTILITY(U,$J,358.3,4907,0)
 ;;=L29.9^^22^301^37
 ;;^UTILITY(U,$J,358.3,4907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4907,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,4907,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,4907,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,4908,0)
 ;;=L40.0^^22^301^41
 ;;^UTILITY(U,$J,358.3,4908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4908,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,4908,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,4908,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,4909,0)
 ;;=L40.3^^22^301^45
 ;;^UTILITY(U,$J,358.3,4909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4909,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,4909,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,4909,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,4910,0)
 ;;=L40.4^^22^301^42
 ;;^UTILITY(U,$J,358.3,4910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4910,1,3,0)
 ;;=3^Psoriasis,Guttate
 ;;^UTILITY(U,$J,358.3,4910,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,4910,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,4911,0)
 ;;=L40.8^^22^301^40
 ;;^UTILITY(U,$J,358.3,4911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4911,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,4911,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,4911,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,4912,0)
 ;;=L89.95^^22^301^30
 ;;^UTILITY(U,$J,358.3,4912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4912,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Unstageable (Covered by Eschar)
 ;;^UTILITY(U,$J,358.3,4912,1,4,0)
 ;;=4^L89.95
 ;;^UTILITY(U,$J,358.3,4912,2)
 ;;=^5133660
 ;;^UTILITY(U,$J,358.3,4913,0)
 ;;=L89.92^^22^301^26
 ;;^UTILITY(U,$J,358.3,4913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4913,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 2
 ;;^UTILITY(U,$J,358.3,4913,1,4,0)
 ;;=4^L89.92
 ;;^UTILITY(U,$J,358.3,4913,2)
 ;;=^5133667
 ;;^UTILITY(U,$J,358.3,4914,0)
 ;;=L89.93^^22^301^27
 ;;^UTILITY(U,$J,358.3,4914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4914,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 3
 ;;^UTILITY(U,$J,358.3,4914,1,4,0)
 ;;=4^L89.93
 ;;^UTILITY(U,$J,358.3,4914,2)
 ;;=^5133668
 ;;^UTILITY(U,$J,358.3,4915,0)
 ;;=L89.94^^22^301^28
 ;;^UTILITY(U,$J,358.3,4915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4915,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 4
 ;;^UTILITY(U,$J,358.3,4915,1,4,0)
 ;;=4^L89.94
 ;;^UTILITY(U,$J,358.3,4915,2)
 ;;=^5133669
 ;;^UTILITY(U,$J,358.3,4916,0)
 ;;=L89.90^^22^301^29
 ;;^UTILITY(U,$J,358.3,4916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4916,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage Unspec
 ;;^UTILITY(U,$J,358.3,4916,1,4,0)
 ;;=4^L89.90
 ;;^UTILITY(U,$J,358.3,4916,2)
 ;;=^5133666
 ;;^UTILITY(U,$J,358.3,4917,0)
 ;;=L89.91^^22^301^25
 ;;^UTILITY(U,$J,358.3,4917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4917,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 1
 ;;^UTILITY(U,$J,358.3,4917,1,4,0)
 ;;=4^L89.91
 ;;^UTILITY(U,$J,358.3,4917,2)
 ;;=^5133664
 ;;^UTILITY(U,$J,358.3,4918,0)
 ;;=L76.21^^22^301^23
 ;;^UTILITY(U,$J,358.3,4918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4918,1,3,0)
 ;;=3^Postprocedure Hemor/Hemtom of Skin/SQ Tissue Following Derm Procedure
 ;;^UTILITY(U,$J,358.3,4918,1,4,0)
 ;;=4^L76.21
 ;;^UTILITY(U,$J,358.3,4918,2)
 ;;=^5009306
 ;;^UTILITY(U,$J,358.3,4919,0)
 ;;=L76.22^^22^301^24
 ;;^UTILITY(U,$J,358.3,4919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4919,1,3,0)
 ;;=3^Postprocedure Hemor/Hemtom of Skin/SQ Tissue Following Oth Procedure
 ;;^UTILITY(U,$J,358.3,4919,1,4,0)
 ;;=4^L76.22
 ;;^UTILITY(U,$J,358.3,4919,2)
 ;;=^5009307
 ;;^UTILITY(U,$J,358.3,4920,0)
 ;;=L41.9^^22^301^3
 ;;^UTILITY(U,$J,358.3,4920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4920,1,3,0)
 ;;=3^Parapsoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,4920,1,4,0)
 ;;=4^L41.9
 ;;^UTILITY(U,$J,358.3,4920,2)
 ;;=^5009177
 ;;^UTILITY(U,$J,358.3,4921,0)
 ;;=L70.5^^22^301^14
 ;;^UTILITY(U,$J,358.3,4921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4921,1,3,0)
 ;;=3^Picker's Acne
 ;;^UTILITY(U,$J,358.3,4921,1,4,0)
 ;;=4^L70.5
 ;;^UTILITY(U,$J,358.3,4921,2)
 ;;=^5009272
 ;;^UTILITY(U,$J,358.3,4922,0)
 ;;=L81.9^^22^301^15
 ;;^UTILITY(U,$J,358.3,4922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4922,1,3,0)
 ;;=3^Pigmentation Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,4922,1,4,0)
 ;;=4^L81.9
 ;;^UTILITY(U,$J,358.3,4922,2)
 ;;=^5009319
 ;;^UTILITY(U,$J,358.3,4923,0)
 ;;=L66.3^^22^301^7
 ;;^UTILITY(U,$J,358.3,4923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4923,1,3,0)
 ;;=3^Perifolliculitis Capitis Abscedens
 ;;^UTILITY(U,$J,358.3,4923,1,4,0)
 ;;=4^L66.3
 ;;^UTILITY(U,$J,358.3,4923,2)
 ;;=^5009255
 ;;^UTILITY(U,$J,358.3,4924,0)
 ;;=R23.3^^22^301^13
 ;;^UTILITY(U,$J,358.3,4924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4924,1,3,0)
 ;;=3^Petechiae
 ;;^UTILITY(U,$J,358.3,4924,1,4,0)
 ;;=4^R23.3
 ;;^UTILITY(U,$J,358.3,4924,2)
 ;;=^5019295
 ;;^UTILITY(U,$J,358.3,4925,0)
 ;;=D69.3^^22^301^43
 ;;^UTILITY(U,$J,358.3,4925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4925,1,3,0)
 ;;=3^Purpura Immune Hemorrhagic/Idopathic Thrombocytopenic
 ;;^UTILITY(U,$J,358.3,4925,1,4,0)
 ;;=4^D69.3
 ;;^UTILITY(U,$J,358.3,4925,2)
 ;;=^332746
 ;;^UTILITY(U,$J,358.3,4926,0)
 ;;=D69.2^^22^301^44
 ;;^UTILITY(U,$J,358.3,4926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4926,1,3,0)
 ;;=3^Purpura Simplex
 ;;^UTILITY(U,$J,358.3,4926,1,4,0)
 ;;=4^D69.2
 ;;^UTILITY(U,$J,358.3,4926,2)
 ;;=^5002366
 ;;^UTILITY(U,$J,358.3,4927,0)
 ;;=L71.9^^22^302^7
 ;;^UTILITY(U,$J,358.3,4927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4927,1,3,0)
 ;;=3^Rosacea,Unspec
 ;;^UTILITY(U,$J,358.3,4927,1,4,0)
 ;;=4^L71.9
 ;;^UTILITY(U,$J,358.3,4927,2)
 ;;=^5009276
 ;;^UTILITY(U,$J,358.3,4928,0)
 ;;=L71.1^^22^302^6
 ;;^UTILITY(U,$J,358.3,4928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4928,1,3,0)
 ;;=3^Rhinophyma
 ;;^UTILITY(U,$J,358.3,4928,1,4,0)
 ;;=4^L71.1
 ;;^UTILITY(U,$J,358.3,4928,2)
 ;;=^106083
 ;;^UTILITY(U,$J,358.3,4929,0)
 ;;=I73.00^^22^302^2
 ;;^UTILITY(U,$J,358.3,4929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4929,1,3,0)
 ;;=3^Raynaud's Syndrome w/o Gangrene
 ;;^UTILITY(U,$J,358.3,4929,1,4,0)
 ;;=4^I73.00
 ;;^UTILITY(U,$J,358.3,4929,2)
 ;;=^5007796
